Go to:
Logótipo
Você está em: Start > Publications > View > MEASUREMENT OF TROUGH-TO-PEAK RATIOS OF 4 ANTIHYPERTENSIVE DRUGS ON THE BASIS OF 24-H AMBULATORY BLOOD-PRESSURE MONITORING - DIFFERENT METHODS MAY GIVE DIFFERENT RESULTS
Publication

MEASUREMENT OF TROUGH-TO-PEAK RATIOS OF 4 ANTIHYPERTENSIVE DRUGS ON THE BASIS OF 24-H AMBULATORY BLOOD-PRESSURE MONITORING - DIFFERENT METHODS MAY GIVE DIFFERENT RESULTS

Title
MEASUREMENT OF TROUGH-TO-PEAK RATIOS OF 4 ANTIHYPERTENSIVE DRUGS ON THE BASIS OF 24-H AMBULATORY BLOOD-PRESSURE MONITORING - DIFFERENT METHODS MAY GIVE DIFFERENT RESULTS
Type
Article in International Scientific Journal
Year
1995
Authors
GAMA, G
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
SANTOS, A
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
POLONIA, J
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 9 No. 7
Pages: 575-580
ISSN: 0950-9240
Publisher: Springer Nature
Scientific classification
FOS: Medical and Health sciences > Clinical medicine
Other information
Authenticus ID: P-001-GPH
Abstract (EN): With 24 h ambulatory blood pressure monitoring (ABPM), the trough-to-peak (T/P) ratios (corrected for placebo) of atenolol 100 mg, cilazapril 2.5 mg, enalapril 20 mg and nifedipine-GITS 30 mg administered once daily for 4 weeks were determined in four groups of hypertensive patients. T/P ratios were calculated by three different methods: directly from the curves that averaged all individual 24 h profiles (A); averaging all individual T/P ratios after ABPM data were averaged for each patient over either 1 h intervals (B) or 3 h intervals (C). Methods B and C produced different values of T/P which, for each drug, were significantly higher with method C. With method A, nifedipine appeared to have the higher T/P. With methods B and C (which in contrast to method A, permitted statistical comparisons), differences between nifedipine and the other drugs were not significant. Meanwhile, method B appears to adhere most closely to FDA guidelines by taking more into account the interindividual variability of BP profile. Thus, we suggest that precise guidelines for measuring T/P on the basis of ABPM are needed, whereas for the comparison between drugs, both the mean value of the T/P and its variance must be determined.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Blood pressure response to mineralocorticoid receptor antagonists or aldosterone synthase inhibitors according to baseline renin levels (2025)
Another Publication in an International Scientific Journal
Leite, AR; Angelico-Gonçalves, A; Leite-Moreira AF; Neves, JS; Ferreira, JP
A comprehensive review on salt and health and current experience of worldwide salt reduction programmes (2009)
Another Publication in an International Scientific Journal
polonia, j; martins, l
Renal and cardiovascular risk predictive value of two different microalbuminuria screening methods in patients with hypertension with/without diabetes in Portugal (2016)
Article in International Scientific Journal
Polonia, J; Carvalho, Davide; Nazaré, J; Martins, L; Da Silva, PM; Aguiar, C; Manso, MC; Carqueja, T
Genetic and environmental factors regulating blood pressure in childhood: Prospective study from 0 to 3 years (1997)
Article in International Scientific Journal
Antonio Guerra; Monteiro, C; Breitenfeld, L; Jardim, H; Carla Rego; Silva, Diana; Prata, A; José Abilio de Oliveira Matos; Costa-Pereira A; Santos, NT; Bicho, M

See all (8)

Recommend this page Top
Copyright 1996-2026 © Faculdade de Farmácia da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2026-02-10 at 14:14:29 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book